Moderna Receives Health Canada Authorization for Updated COVID-19 Vaccine SPIKEVAX XBB.1.5
- Health Canada has authorized updated COVID-19 vaccines SPIKEVAX targeting the Omicron XBB.1.5 subvariant in individuals aged ≥6mos. Provinces and territories will have access to COVID-19 vaccines for their respective fall vaccination campaigns
- The additional clinical trial data showed that the updated COVID-19 vaccine elicited an immune response in humans against EG.5, FL.1.5.1 & BA.2.86
- Additionally, the vaccine will be available in one presentation (0.1mg/mL 2.5mL vial) allowing for adult and paediatric doses to be drawn from the same vial
Ref: Newswire | Image: Moderna
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at email@example.com
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at firstname.lastname@example.org.